Ascent Wealth Partners’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-12,245
Closed -$3.99M 167
2024
Q1
$3.99M Buy
12,245
+252
+2% +$61.9K 0.59% 48
2023
Q4
$2.29M Buy
11,993
+2,032
+20% +$384K 0.37% 56
2023
Q3
$1.98M Buy
9,961
+4,406
+79% +$1.04M 0.37% 59
2023
Q2
$1.54M Buy
5,555
+271
+5% +$75.3K 0.27% 73
2023
Q1
$1.15M Buy
5,284
+85
+2% +$16.6K 0.23% 91
2022
Q4
$1.07M Buy
5,199
+26
+0.5% +$6.57K 0.23% 92
2022
Q3
$1.44M Sell
5,173
-427
-8% -$109K 0.34% 66
2022
Q2
$1.03M Buy
5,600
+488
+10% +$86.1K 0.23% 86
2022
Q1
$1.06M Buy
5,112
+24
+0.5% +$3.96K 0.2% 80
2021
Q4
$908K Buy
5,088
+229
+5% +$45.2K 0.16% 85
2021
Q3
$1M Sell
4,859
-32
-0.7% -$6.28K 0.19% 82
2021
Q2
$928K Buy
+4,891
New +$800K 0.18% 83

Other funds holding SWAV

Ascent Wealth Partners's SWAV Position: Q2 2024 in Review

Ascent Wealth Partners sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 12,245 shares — an estimated $3.99M sold.

Ascent Wealth Partners first reported a position in SWAV in Q2 2021 and held it in 12 quarters. The position peaked at $3.99M in Q1 2024. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

  • Ascent Wealth Partners reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Ascent Wealth Partners sold 12,245 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $3.99M.
  • Ascent Wealth Partners first reported a position in Shockwave Medical, Inc. Common Stock in Q2 2021 and held it in 12 quarters.
  • Ascent Wealth Partners's Shockwave Medical, Inc. Common Stock position peaked at $3.99M in Q1 2024.
  • 7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on Ascent Wealth Partners's 13F filing for Q2 2024, filed 31 Jul 2024.